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Muscarinic acetylcholine receptors purified from porcine atrium were phosphorylated, depending on the presence of agonists, by a protein kinase 
partially purified from porcine brain, which had similar properties to the )%adrenergic receptor kinase. GTP-binding regulatory proteins (Go) had 
dual effects on the phosphorylation of muscarinic receptors, i.e. stimulation at lower concentrations and inhibition at higher concentrations. The 
stimulatory effect was reproduced with the By subunit of Go and the inhibitory effect with the combination of the a and By subunits. 
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Rhodopsin kinase 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Muscarinic acetylcholine receptors have been shown 
to be members of the receptor family which is charac- 
terized by the seven putative transmembrane segments 
[l-6] and the interaction with G proteins [7-lo]. On 
the other hand, knowledge on the regulation of recep- 
tor functions is still limited [5,6,11]. Kwatra et al. 
reported that agonist-dependent phosphorylation of 
muscarinic receptors in chick heart may result in their 
desensitization [ 12,131 and that purified cardiac recep- 
tors are phosphorylated [ 141 by fl-adrenergic receptor 
kinase, which is suggested to be involved in the 
homologous desensitization of &adrenergic receptors 
[ 151. We have also found that both cerebral and atria1 
muscarinic receptors are phosphorylated, depending on 
the presence of agonists, by a protein kinase partially 
purified from porcine cerebrum, and that the phospho- 
rylation is inhibited by excess G proteins (Go) in the 
absence of a guanine nucleotide but not in the presence 
of either GTP or GDP [16]. In the present report, we 
provide evidence that the phosphorylation is dually 
regulated by G proteins. 
The protein kinase was partially purified from porcine cerbrum by 
a modification of the method used previously for the purification of 
,&adrenergic receptor kinase [17], as described 1161. The specific ac- 
tivity of the preparation was estimated to be 13 pmol/min/mg pro- 
tein with 50 FM ATP and 1.1 nM muscarinic receptors as substrates 
in the presence of 1 mM carbamylcholine, 15 nM Go and 10 CM 
GTP-,S. The K,,, for muscarinic receptors of the present preparation 
has not been determined. If we assume that the K,,, is the same as 
those for rhodopsin (6rM) or,&adrenergic receptors (0.25rM) of the 
,&adrenergic receptor kinase [17], the specific activity (V,.,) is 
estimated to be 71 or 3 nmol/min/mg protein, respectively, which is 
comparable to the value (7.2 nmol/min/mg protein) reported for the 
,&adrenergic receptor kinase preparation (purity 10%) [17]. Con- 
taminations of protein kinase C, CAMP-dependent protein kinase, 
phosphatases and ATPases in the present preparation were negligible 
(data not shown). 
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Muscarinic receptors were purified from porcine atrium by a single 
step of affinity chromatography (18,191 (sp. act. 2 nmol/mg protein, 
as assessed from [.‘H]QNB binding activity), and Go from porcine 
cerebrum as described [9] (sp. act. 8 nmol/mg protein, as assessed 
from [35S]GTPyS binding activity). The (Y subunit of Go was 
prepared as described [20] and kindly donated by Dr T. Asano. The 
& subunit of Go was isolated from a Go preparation by means of 
DEAE-Toyopearl column chromatography, following incubation of 
the Go with 50 rM GTPyS and 50 mM MgCla [21]. The concentra- 
tions of Go and o subunits were estimated from the [35S]GTPrS 
binding activity, and that of the & subunit was estimated by com- 
parison of the densities of B bands stained with Coomassie brilliant 
blue following SDS-PAGE of the Go and fir subunit preparations. 
Abbreviations: G protein, GTP-binding regulatory protein; Go, a G 
protein with (Y subunit of apparent molecular mass of 39 kDa; 
[‘H]QNB, [3H]L-quinuclidinyl benzylate; GTPrS, guanosine 
5 ’ -(3-O-thio)triphosphate; SDS-PAGE, sodium dodecyl sulfate poly- 
acrylamide gel electrophoresis; Hepes, 4-(2-hydroxyethyl)-l-piper- 
azineethanesulfonic acid; DTT, dithiothreitol 
Muscarinic receptors in 0.1% digitonin/0.5 M K-phosphate buffer 
(pH 7)/10 mM carbamylcholine (30 pmol, 50~1) were mixed with G 
proteins or G protein subunits in a buffer solution containing 0.3% 
sodium cholate (480 pmol in standard experiments, 25 /cl), lipid in a 
Hepes buffer solution (HEN; 20 mM Hepes buffer (pH 8)/l mM 
EDTA1160 mM NaCl) containing 0.04% sodium cholate and 0.18% 
sodium deoxycholate (0.15 mg each of a total lipid extract of porcine 
brain and Folch fraction I (Sigma), 100 rl), and HEN (total volume, 
200~1). The mixture was passed through a small column of Sephadex 
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G 50 fine (2 ml) preequilibrated with HEN and the void volume frac- 
tion (400 ~1) was collected. The recoveries of the [‘H]QNB and 
[“S]GTPyS binding activities in the void volume fraction were 24% 
and 62070, respectively. The void volume fraction (50 ~1) was in- 
cubated with the kinase preparation (3.7 fig of protein), 1 pM 
[32P]ATP (5x lo5 cpm per tube), 10 PM GTPyS and muscarinic 
ligands in a solution comprising 20 mM Tris buffer (pH 7.5)/2 mM 
EDTA/S mM MgCW0.5 mM EGTA (total volume, 300&. After in- 
cubation for 60 min at 3O”C, 2 ml of HEN was added and then the 
mixture was centrifuged for 30 min at 190 OOOxg. The pellet was 
suspended in a solution containing 2.5% SDS (60,ul), and then a por- 
tion (40 ~1) of the suspension was subjected to SDS-PAGE (acryl- 
amide concentration, 10%) followed by autoradiography. The band 
of muscarinic receptors was cut out and counted by the use of 
Cerenkov’s effect. The recoveries of the [‘H]QNB and [“S]GTPyS 
binding activities after the centrifugation were estimated to be 43 and 
34%, respectively. 
3. RESULTS 
Muscarinic receptors were purified from porcine 
atrium [18], reconstituted with G proteins in lipid 
vesicles [9] and then subjected to phosphorylation with 
a protein kinase. Fig. 1 shows the effects of the concen- 
trations of carbamylcholine and atropine on the 
phosphorylation. Muscarinic receptors were phosphor- 
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Fig. 1. Effects of the concentrations of carbamylcholine and 
atropine. Muscarinic receptors purified from porcine atrium and then 
reconstituted with Go were phosphorylated with a protein kinase, 
which was partially purified from porcine cerebrum, in the presence 
of different concentrations of carbamylcholine or 1 mM car- 
bamylcholine and different concentrations of atropine, followed by 
SDS-PAGE, autoradiography (b) and counting of the receptor band 
(a). 
ylated in the presence of carbamylcholine but not in its 
absence and were the only major proteins phosphory- 
lated, no phosphorylation of G proteins being detected. 
The concentration of carbamylcholine giving the half- 
maximum effect was 13 PM and the concentration of 
atropine decreasing the effect of I mM car- 
bamylcholine to 50% was 0.5 PM, which corresponds 
to an apparent dissociation constant of 6.4 nM on the 
assumption of a mass action. Thus, the effective con- 
centrations of carbamylcholine and atropine are essen- 
tially the same as those in the absence of G proteins 
[ 14,161. These apparent & values are comparable to 
those estimated from the [3H]QNB binding experi- 
ments [9,10], confirming that the effects of carbamyl- 
choline and atropine are due to their ‘binding to 
muscarinic receptors. The agonist-dependent phos- 
phorylation of muscarinic receptors by the present 
kinase preparation was not affected by CAMP or 
cGMP, did not require the presence of Ca and was in- 
hibited by 0.15 M NaCl or KC1 [16], which are proper- 
ties common to the &adrenergic receptor kinase [17]. 
In addition, the activity was found to be inhibited by 1 
PM heparin (data not shown), as was reported for the 
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Fig. 2. Effect of the concentration of Go. Atria1 muscarinic receptors 
reconstituted with different concentrations of Go were phosphor- 
ylated with the protein kinase in the presence (closed symbols) or 
absence (open symbols) of 10 PM GTP-,S in the presence of 1 mM 
carbamylcholine or 10 CM atropine (broken line), followed by SDS- 
PAGE, autoradiography (b) and counting of the receptor band (a). 
The results of five independent experiments are plotted, using dif- 
ferent symbols (a). Reconstitution and phosphorylation were carried 
out as described in the text, except hat various concentrations of Go 
were used. Concentrations of Go in the phosphorylation reaction 
mixture are shown in the abscissa and that of receptors is 1.1 nM. 
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phosphorylation of ,&adrenergic receptors by ,&adre- 
nergic receptor kinase [22]. These results indicate that 
the relevant kinase is very similar to, if not identical 
with, the ,6-adrenergic receptor kinase. 
The effects of various concentrations of Go on the 
phosphorylation of atria1 receptors (1.1 nM) are sum- 
marized in Fig. 2. The phosphorylation of receptors in 
the absence of a guanine nucleotide increased with Go 
concentrations up to approximately 2 nM and then 
markedly decreased with a further increase in the Go 
concentration, no phosphorylation being observed in 
the presence of more than 30 nM Go. On the other 
hand, the decreasing phase was not observed in the 
presence of GTPyS, the phosphorylation increasing up 
to approximately 3 nM Go and then remaining essen- 
tially the same, or only slightly decreasing from 3 to 50 
nM Go. Essentially the same results were obtained with 
Gi (Ed&) or Gn (cu&), as well as with Go, and also 
with cerebral muscarinic receptors and one of the three 
G proteins (data not shown). 
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Fig. 3. Effects of the cy and ,8y subunits of Go. Atrial muscarinic 
receptors were reconstituted with Go, the LY subunit of Go, the & 
subunit of Go or a mixture of the (Y and fly subunits and then sub- 
jected to phosphorylation in the presence of 1 mM carbamylcholine 
in the presence or absence of 10 pM GTPyS (concentrations of Go 
and Go subunits in the phosphorylation medium, 1.5 (a) and 15 nM 
(b)). The stained bands of CY andbsubunits on SDS-PAGE are shown 
in (c). 
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Fig. 4. Effects of incubation time and concentrations of ATP. Atria1 
muscarinic receptors were reconstituted with or without the ,L$ 
subunit and then subjected to phosphorylation in the presence of 10 
pM GTPyS and 1 mM carbamylcholine or 10fiM atropine (broken 
line) with (a) 5 PM or (b, c) various concentrations of ATP for (a) 
varied periods, (b) 15 min or (c) 120 min (concentrations of receptors, 
,& subunits and the kinase are 1.1 nM, 15 nM, and 4.9pg protein per 
tube, respectively). The differences in [3ZP]phosphates incorporated 
in the presence of carbamylcholine and those incorporated in the 
presence of atropine were shown as closed symbols in (a), (b) and (c). 
45 
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G proteins are known to be composed of cy, L? and y 
subunits, the trimer being split into LY and .& subunits 
on the addition of GTPyS [23]. To determine which of 
the CY and fly subunits is responsible for the stimulation 
and inhibition of the agonist-dependent phosphoryla- 
tion of muscarinic receptors, they were separated from 
each other and their effects on the phosphorylation 
were examined, Fig. 3 summarizes their effects at two 
concentrations, 1.5 and I5 nM. The stimulation of the 
phosphorylation was observed by the & subunits but 
not by the cy subunits. The stimulation by & subunits 
was also dependent on the presence of an agonist and 
was blocked on the addition of atropine (data not 
shown). The@y subunit stimulated the phosphorylation 
as much as Go did, the effective concentration of ,& 
subunits being similar to those of Go. The difference 
between the effects of Go and by subunits is that the 
stimulation by fly subunits was independent of GTPyS 
at both 1.5 and 15 nM, whereas there was marked in- 
hibition of the phosphorylation at 15 nM Go in the 
absence of GTPyS, but not in its presence. 
The LY subunit at 1.5 nM showed neither a 
stimuiatory nor an inhibitory effect, and did not affect 
the stimulation by& subunits. The a subunit at 15 nM, 
however, suppressed the phosphorylation in the 
presence of 15 nM ,&y subunits in the absence of 
GTPyS, but not in its presence. Thus the stimulatory 
and inhibitory effects of Go were reproduced by the fly 
subunit, and the mixture of cy and ,0y subunits, respec- 
tively. 
Fig. 4 demonstrates the time course of phosphoryla- 
tion in the absence and presence of ,&y subunits at 5 FM 
ATP (Fig. 4a), and the effects of concentrations of 
ATP on the phosphorylation at the incubation time of 
15 min (Fig. 4b) and 120 min (Fig.4c). The stimulatory 
effect of fly subunit was greater on the initial rate 
(V,,,) rather than on the &, for ATP or the extent of 
phosphorylation. The apparent K, for ATP were es- 
timated to be 8 and 16 PM, and Max to be 9.1 and 1.4 
pmol/min/mg protein at the receptor concentration of 
1 .l nM in the presence and absence of fly subunits, 
respectively. The amounts of phosphate incorporated 
into receptors after incubation of 120 min with 50 FM 
ATP were 8.4 and 4.1 moI/mol of receptor in the 
presence and absence of & subunits, respectively. 
4. DISCUSSION 
It is known that both cerebral [7-9,21,24] and atria1 
110,251 muscarinic receptors reconstituted with one of 
the three G proteins (Gi, Go, Gn) show high affinity for 
agonists in the absence of a guanine nucleotide but low 
affinity in its presence, and that the proportion of 
guanine nucleotide-sensitive high affinity agonist bind- 
ing increases with an increase in the G protein concen- 
tration. The concentrations of G proteins required for 
the maximum effect differ depending on the experi- 
46 
mental conditions, being reported to be a only 3-fold 
excess of cardiac Gi over atria1 receptors by Tota et al. 
[lo], and an SOO-fold excess of Go over cerebral recep- 
tors by Florio and Sternweis [24]. Under the present 
experimental conditions, the guanine nucleotide- 
sensitive high affinity agonist binding increased from a 
2- to 20-fold excess Go over atria1 receptors, in accor- 
dance with the previous results [9,21,25]. The inhibi- 
tion of agonist-dependent phosphorylation by Go in 
the absence of GTPyS occurred in the same Go concen- 
tration range (Fig. 2). In addition, the high affinity 
agonist binding and the inhibition of ago~st-dependent 
phosphorylation, both of which are induced on the ad- 
dition of excess G proteins, are canceled on the addi- 
tion of either GTP or GDP, as well as GTPyS 19,161. 
The concentrations of GTP and GDP giving half- 
maximum effects as to restoration of the inhibition of 
agonist-dependent phosphorylation were 0.3 and 0.8 
PM, respectively (data not shown). These levels are a 
little higher than those of GTP and GDP giving half- 
maximum effects on the high affinity agonist binding 
(0.07 and 0.18 PM [9], respectively). Furthermore, the 
finding that both cr and& subunits are required for the 
inhibition of agonist-dependent phosphorylation is 
consistent with the observation that the interaction of 
muscarinic receptors with both cy and @y subunits is re- 
quired for the guanine nucleotide sensitive high affinity 
agonist binding [‘7,24]. These results, taken together, 
indicate that the inhibition by G proteins of the agonist- 
dependent phosphorylation of muscarinic receptors oc- 
curs in parallel with the high affinity agonist binding of 
muscarinic receptors reconstituted with G proteins. It 
would be reasonable to assume that the guanine 
nucleotide-sensitive high affinity agonist binding 
represents the formation of a ternary complex of an 
agonist, a receptor and a G protein, which dissociates 
on the addition of GTP or GDP, and that the agonist- 
dependent phosphorylation of muscarinic receptors is 
inhibited on the formation of the ternary complex, 
probably through masking by G proteins of the phos- 
phorylation sites on receptors. Consistent with the pre- 
sent results, Kelleher and Johnson [26] reported that 
the light-dependent phosphorylation of rhodopsin by 
rhodopsin kinase was inhibited by a retinal G protein, 
transducin, and that the inhibition was relieved in the 
presence of GTPyS. 
The stim~ation of phosphorylation by fiy subunits, 
on the other hand, is the phenomenon which was found 
for the first time in the present system, and such a 
stimulation was not observed in the rhodopsin-trans- 
ducin system [26] and it is not known if the 
phosphorylation of ,&adrenergic receptors by ,& 
adrenergic receptor kinase is regulated by G proteins or 
not. The target of the ,&y subunit has not been deter- 
mined and may be the receptor or the receptor kinase. 
Whichever the target of fly subunits is, it is tempting to 
speculate that the fly subunit stimulates the 
Volume 268, number 1 FEBS LETTERS July 1990 
phosphorylation of receptors thereby facilitating their 
desensitization, whereas the CY subunits affect the ef- 
fectors. 
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